MedPath

clinical evaluation of siddha drug samuthrapazha nei in the treatment of Maxillary sinusitis (Neer peenisam)

Phase 3
Conditions
Health Condition 1: null- NEER PEENISAM (Maxillary sinusitis)
Registration Number
CTRI/2017/03/008053
Lead Sponsor
Ayothidhasar Pandithar Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1)18-50 years

2)Both male & female

3)The symptoms of pain in the face purulent

nasal discharge and headache/heaviness of

head sneezing fever tooth ache nasal block

and presence of any three symptoms will be

taken as inclusion criteria.

4)Patient willing to sign the informed consent

stating that he/she will conscientiously stick to the treatment during 48 days but can opt out of the trial of his/her own conscious discretion.

5)Patients who are willing for radiological

investigation (X-ray for Paranasal sinuses) and

provide blood urine for lab investigation.

Exclusion Criteria

1) Bronchial asthma

2)Tuberculosis

3)Diabetes mellitus

4)Hypertension

5)Pregnancy and lactation

6)Heart disease

7)Chronic obstructive pulmonary disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath